Plain language summary of Pfizer-BioNTech BNT162b2 COVID-19 vaccine safety in participants 16 years or older and protection against COVID-19 in participants 12 years or older

This plain language summary from Future Virology describes part of a clinical study of the Pfizer-BioNTech COVID-19 vaccine. The part of the study described was ongoing at the time of publication, meaning the final results may be different from the results included in this summary.

Read the full article here.

The original article on which this plain language summary is based is titled ‘Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months’ and was published in the New England Journal of Medicine. Read the original article here.